Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.76 USD | +0.61% | +4.35% | -29.36% |
04-20 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
04-20 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.36% | 4.3B | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Wolfe Research Starts Immunovant With Outperform Rating, $55 Price Target